{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/ovarian-cancer/background-information/prognosis/","result":{"pageContext":{"chapter":{"id":"e5f859f0-168b-5395-a133-af2778a0ef84","slug":"prognosis","fullItemName":"Prognosis","depth":2,"htmlHeader":"<!-- begin field 7ab00a62-6b24-4739-b017-5f6ba93065c0 --><h2>What is the prognosis?</h2><!-- end field 7ab00a62-6b24-4739-b017-5f6ba93065c0 -->","summary":"","htmlStringContent":"<!-- begin item ce237ec5-5a65-46e5-9a35-5007fde38ce2 --><!-- begin field 0d6ad1b8-53f9-44f8-8c06-61a3f0d02bb9 --><ul><li><strong>The survival rate for ovarian cancer is strongly related to the stage of the disease at the time of diagnosis. </strong>Generally, women diagnosed with early (stage I or II) ovarian cancer have a better one-year survival than those diagnosed with late (stage IV) cancer [<a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">Cancer Research UK, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">Office for National Statistics, 2016</a>].</li><li><strong>A statistical bulletin published by the Office for National Statistics on cancer survival by stage at diagnosis reported that in England<em> </em></strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">Office for National Statistics, 2016</a>]<strong>:</strong><ul><li>There was a steadily decreasing survival with increasing stage, but survival for women diagnosed at stage I was high: 99% of women diagnosed at stage I survived the disease for at least one year compared with 51% of women diagnosed at stage IV.</li><li>Almost 50% of women diagnosed with ovarian cancer were diagnosed at stages III and IV.</li><li>In 2012–2014, the overall survival rate for women diagnosed with ovarian cancer was 71%. </li></ul></li><li><strong>Cancer Research UK statistics on ovarian cancer reported that </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">Cancer Research UK, 2015</a>]<strong>:</strong><ul><li>Five-year survival for ovarian cancer shows a rapid decrease in survival between stages I and IV. <ul><li>In 2002–2006, the five-year relative survival ranged from 90% for women diagnosed at stage I to 4% for women diagnosed at stage IV.</li></ul></li><li>Of women diagnosed with ovarian cancer in England and Wales in 2010–2011, 35% survived the disease for ten years or more, 46% survived the disease for five years or more, and 73% survived the disease for one year or more.</li><li>Ovarian cancer survival rate in England was highest for women aged under 40 years at the time of diagnosis.<ul><li>In 2009–2013, almost 90% of women in England diagnosed with ovarian cancer aged 15–39 survived the disease for five years or more compared with 20% of women diagnosed aged 80 years and over.</li></ul></li><li>Ovarian cancer survival is improving and has almost doubled in the last 40 years in the UK.<ul><li>In the 1970s, less than 20% of women diagnosed with ovarian cancer survived the disease beyond ten years compared with more than 30% in recent years.</li><li>Mortality rates for ovarian cancer are projected to fall by 37% in the UK between 2014–2035, to 10 deaths per 100,000 women by 2035.</li></ul></li></ul></li></ul><!-- end field 0d6ad1b8-53f9-44f8-8c06-61a3f0d02bb9 --><!-- end item ce237ec5-5a65-46e5-9a35-5007fde38ce2 -->","topic":{"id":"e76d1533-c4e4-5615-b47d-b9a78e802a8c","topicId":"2b5f9995-52a6-4997-b11b-4dd86f5b4cac","topicName":"Ovarian cancer","slug":"ovarian-cancer","lastRevised":"Last revised in July 2018","chapters":[{"id":"00f52bf3-2854-5c26-896d-9e19a7a50ffa","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"1978d14c-1832-5012-aad2-ae688f64a4f0","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"39ed13eb-bf02-5897-9546-f63bb13e1312","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"b6205ec5-8fed-5fa0-9459-17c9ed9797a4","slug":"changes","fullItemName":"Changes"},{"id":"dff67d8b-2740-5711-b49a-d03a83243ab3","slug":"update","fullItemName":"Update"}]},{"id":"4d027c28-c2b3-5578-8eab-c2029d5b3347","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"f40d2697-554a-5249-abb4-6247e9db5eca","slug":"goals","fullItemName":"Goals"},{"id":"6b3fba32-56cd-5102-879a-64cb859b80ef","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"8e5550d6-e4d8-54a5-8046-0542cdf4be38","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"c7811d8a-c44d-5470-8e72-e0a8ff4d2d61","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"816a9080-6571-5a58-bfe1-04411127e3d2","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"4afe1f86-c28e-51bf-8c7f-39373606165d","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"39f05ca6-5cf0-5e67-af39-03983de815d1","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"03b4909c-fc38-5af3-848f-1df54131e0c5","slug":"definition","fullItemName":"Definition"},{"id":"83553e71-1f1a-543b-be50-09b4c7b8c224","slug":"incidence","fullItemName":"Incidence"},{"id":"c8597bdc-f028-5141-85c3-c6b429bf7d78","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"e5f859f0-168b-5395-a133-af2778a0ef84","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"4d5f7685-3efd-5198-90e1-d8cb8f470a28","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"26a540a4-c12b-5ae8-b3de-eb2d3472a824","slug":"when-to-suspect-ovarian-cancer","fullItemName":"When to suspect ovarian cancer"},{"id":"d7d39f7a-9f30-588c-9589-b8c8b5a76729","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"d02788d8-8b2d-5672-8eca-dfcc643a2055","fullItemName":"Management","slug":"management","subChapters":[{"id":"e47609d5-133b-5929-ad56-44ab30116871","slug":"managing-a-woman-with-suspected-ovarian-cancer","fullItemName":"Scenario: Managing a woman with suspected ovarian cancer"}]},{"id":"99dcdee4-9931-5ef8-a3d8-d86417646b02","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"9b4bd4c6-cb71-5783-8529-7346c25fc30f","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"11ba9663-4a8b-516e-a825-1f8d766c7041","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"ec67bf69-9ccc-5c53-81da-f2c0713d4527","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"bcf5ab6b-23af-5b9a-bbcd-22d0002e20cf","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"ac95df2b-f68f-5f64-bb51-88ff094f74b8","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"23bfe348-903c-5728-b9b9-71e7975e7e53","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"faaa4aff-4567-544b-af9e-b7dc24fae5df","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"39f05ca6-5cf0-5e67-af39-03983de815d1","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}